Skip to content

To analyse Heart Rate variability in hypertensive individuals

DETRENDED FLUCTUATION ANALYSIS (DFAa1) OF HEART RATE VARIABILITY IN HYPERTENSIVE INDIVIDUALS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/098160
Enrollment
86
Registered
2025-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Department Of General Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with hypertension (BP more than 135/85 OR office bp more than 140/90) Diagnosis of hypertension should be based on at least 2 measurements taken in the clinic or by a healthcare provider on at least 2 visits, which are at least 1-4 weeks apart except in the case of hypertensive urgencies and hypertensive emergencies, where hypertension is diagnosed during the first visit itself. Ambulatory blood pressure monitoring and home based BP monitoring is not feasible for diagnosis for most patients with hypertension in India and is therefore not recommended. Both males and females

Exclusion criteria

Exclusion criteria: SECONDARY HYPERTENSION TYPE 1, 2 DIABETES MELLITUS ACUTE CORONARY SYNDROME CHRONIC KIDNEY DISEASE- EGFR less than 60MLMIN1.73M2 HEART FAILURE CARDIOMYOPATHY ARRHYTHMIA VALVULAR HEART DISEASE COPD POLYNEUROPATHY, PERIPHERAL VASCULAR DISEASE BMI more than 40 PSYCHIATRIC Disorders (PRECLUDING PATIENT COOPERATION) PATIENT ON PERMANENT PACEMAKER ECG TRACING WITH PREMATURE COMPLEXES, ARTIFACTS HYPERTHYROIDISM and or HYPOTHYROIDISM PREGNANCY

Design outcomes

Primary

MeasureTime frame
To Analyze Detrended fluctuation analysis (DFAa1) of heart rate variability in hypertensive individuals and To evaluate relationship between heart rate variability (DFAa1) and hypertension To correlate between HRV (DFAa1) value obtained and changes seen in serum sodium, potassium, calcium levels at that point of time. Timepoint: CROSS SECTIONAL STUDY over 2 years

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Aayushi Bhagwat

Kasturba medical college manipal

mm.prabhu@manipal.edu7898915790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026